The opioid-exposed newborn: assessment and pharmacologic management

J Opioid Manag. Jan-Feb 2009;5(1):47-55.

Abstract

The infant exposed to opioids in utero frequently presents a challenge to the neonatal care provider in the assessment and treatment of symptoms of Neonatal Abstinence Syndrome (NAS) after birth. This review is intended to provide the healthcare professional with a brief review of current evidence and practical guidelines for optimal evaluation and pharmacologic management of the opioid-exposed newborn.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Drug Therapy, Combination
  • Female
  • Humans
  • Infant, Newborn
  • Maternal Exposure
  • Maternal-Fetal Exchange
  • Methadone / administration & dosage
  • Methadone / therapeutic use*
  • Morphine / administration & dosage
  • Morphine / therapeutic use*
  • Narcotics / administration & dosage
  • Narcotics / therapeutic use*
  • Neonatal Abstinence Syndrome / diagnosis
  • Neonatal Abstinence Syndrome / drug therapy*
  • Opioid-Related Disorders / diagnosis
  • Opioid-Related Disorders / drug therapy*
  • Opioid-Related Disorders / rehabilitation
  • Practice Guidelines as Topic
  • Pregnancy
  • Prenatal Exposure Delayed Effects / drug therapy*

Substances

  • Narcotics
  • Morphine
  • Methadone